{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T01:17:46Z","timestamp":1783732666890,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"7-8","license":[{"start":{"date-parts":[[2016,5,3]],"date-time":"2016-05-03T00:00:00Z","timestamp":1462233600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s11046-016-0011-x","type":"journal-article","created":{"date-parts":[[2016,5,3]],"date-time":"2016-05-03T06:31:06Z","timestamp":1462257066000},"page":"505-511","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Comparison of Serum Galactomannan and 1,3-Beta-d-Glucan Determination for Early Detection of Invasive Pulmonary Aspergillosis in Critically Ill Patients with Hematological Malignancies and Septic Shock"],"prefix":"10.1007","volume":"181","author":[{"given":"Tobias","family":"Lahmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Rasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Schnappauf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Analena","family":"Beitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland M.","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,3]]},"reference":[{"issue":"5","key":"11_CR1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jinf.2012.08.003","volume":"65","author":"WJ Steinbach","year":"2012","unstructured":"Steinbach WJ, Marr KA, Anaissie EJ, et al. Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry. J Infect. 2012;65(5):453\u201364.","journal-title":"J Infect"},{"issue":"1","key":"11_CR2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1086\/320871","volume":"33","author":"E Ninin","year":"2001","unstructured":"Ninin E, Milpied N, Moreau P, et al. Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants. Clin Infect Dis. 2001;33(1):41\u20137.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"11_CR3","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1086\/510592","volume":"44","author":"A Upton","year":"2007","unstructured":"Upton A, Kirby KA, Carpenter P, et al. Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clin Infect Dis. 2007;44(4):531\u201340.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"11_CR4","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1086\/522189","volume":"45","author":"L Pagano","year":"2007","unstructured":"Pagano L, Caira M, Nosari A, et al. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study\u2014Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. Clin Infect Dis. 2007;45(9):1161\u201370.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"11_CR5","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/cid\/civ293","volume":"61","author":"OA Cornely","year":"2015","unstructured":"Cornely OA, Gachot B, Akan H, EORTC Infectious Diseases Group, et al. Epidemiology and outcome of fungemia in a cancer Cohort of the Infectious Diseases Group (IDG) of the European Organization for Research and Treatment of Cancer (EORTC 65031). Clin Infect Dis. 2015;61(3):324\u201331.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"11_CR6","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"B Pauw De","year":"2008","unstructured":"De Pauw B, Walsh TJ, Donnelly JP, European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group, National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group. Clin Infect Dis. 2008;46(12):1813\u201321.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"11_CR7","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1128\/JCM.37.10.3223-3228.1999","volume":"37","author":"J Maertens","year":"1999","unstructured":"Maertens J, Verhaegen J, Demuynck H, et al. Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive aspergillosis. J Clin Microbiol. 1999;37(10):3223\u20138.","journal-title":"J Clin Microbiol"},{"key":"11_CR8","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/bmt.2011.178","volume":"47","author":"O Marchetti","year":"2012","unstructured":"Marchetti O, Lamoth F, Mikulska M, et al. ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients. Bone Marrow Transplant. 2012;47:846\u201354.","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"11_CR9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00134-012-2769-8","volume":"39","author":"RP Dellinger","year":"2013","unstructured":"Dellinger RP, Levy MM, Rhodes A, Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39(2):165\u2013228.","journal-title":"Intensive Care Med"},{"key":"11_CR10","doi-asserted-by":"crossref","first-page":"562","DOI":"10.4065\/75.6.562","volume":"75","author":"J Roosen","year":"2000","unstructured":"Roosen J, Frans E, Wilmer A, et al. Comparison of premortem clinical diagnoses in critically ill patients and subsequent autopsy findings. Mayo Clin Proc. 2000;75:562\u20137.","journal-title":"Mayo Clin Proc"},{"key":"11_CR11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1086\/518852","volume":"45","author":"W Meersseman","year":"2007","unstructured":"Meersseman W, Lagrou K, Maertens J, et al. Invasive aspergillosis in the intensive care unit. Clin Infect Dis. 2007;45:205\u201316.","journal-title":"Clin Infect Dis"},{"key":"11_CR12","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1473-3099(05)70238-3","volume":"5","author":"WW Hope","year":"2005","unstructured":"Hope WW, Walsh TJ, Denning DW. Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis. 2005;5:609\u201322.","journal-title":"Lancet Infect Dis"},{"key":"11_CR13","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1128\/CDLI.10.5.882-885.2003","volume":"10","author":"J Digby","year":"2003","unstructured":"Digby J, Kalbfleisch J, Glenn A, et al. Serum glucan levels are not specific for presence of fungal infections in Intensive Care Unit patients. Clin Diagn Lab Immunol. 2003;10:882\u20135.","journal-title":"Clin Diagn Lab Immunol"},{"key":"11_CR14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1164\/rccm.200704-606OC","volume":"177","author":"W Meersseman","year":"2008","unstructured":"Meersseman W, Lagrou K, Maertens J, et al. Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. Am J Respir Crit Care Med. 2008;177:27\u201334.","journal-title":"Am J Respir Crit Care Med"},{"key":"11_CR15","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1086\/432470","volume":"41","author":"L Ostrosky-Zeichner","year":"2005","unstructured":"Ostrosky-Zeichner L, Alexander B, Kett D, et al. Multicenter clinical evaluation of the (1\u00a0\u2192\u00a03)-\u03b2-d-glucan assay as an aid to diagnosis of fungal Infections in humans. Clin Infect Dis. 2005;41:654\u20139.","journal-title":"Clin Infect Dis"},{"key":"11_CR16","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1086\/647942","volume":"49","author":"S Koo","year":"2009","unstructured":"Koo S, Bryar JM, Page JH, et al. Diagnostic performance of the (1-3)\u2013D-glucan assay for invasive fungal disease. Clin Infect Dis. 2009;49:1650\u20139.","journal-title":"Clin Infect Dis"},{"key":"11_CR17","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/cid\/ciq206","volume":"52","author":"DE Karageorgopoulos","year":"2011","unstructured":"Karageorgopoulos DE, Vouloumanou EK, Ntziora F, et al. Beta-d-Glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. Clin Infect Dis. 2011;52:750\u201370.","journal-title":"Clin Infect Dis"},{"key":"11_CR18","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/cid\/cir897","volume":"54","author":"F Lamoth","year":"2012","unstructured":"Lamoth F, Cruciani M, Mengoli C, Third European Conference on Infections in Leukemia (ECIL-3), et al. Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3). Clin Infect Dis. 2012;54:633\u201343.","journal-title":"Clin Infect Dis"},{"key":"11_CR19","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1086\/503427","volume":"42","author":"CD Pfeiffer","year":"2006","unstructured":"Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis. 2006;42:1417\u201327.","journal-title":"Clin Infect Dis"},{"key":"11_CR20","first-page":"CD007394","volume":"4","author":"MM Leeflang","year":"2008","unstructured":"Leeflang MM, Debets-Ossenkopp YJ, Visser CE, et al. Galactomannan detection for invasive aspergillosis in immunocompromised patients. Cochrane Database Syst Rev. 2008;4:CD007394.","journal-title":"Cochrane Database Syst Rev"},{"key":"11_CR21","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1128\/JCM.00879-11","volume":"49","author":"G Vlieger De","year":"2011","unstructured":"De Vlieger G, Lagrou K, Maertens J, et al. Beta-d-Glucan detection as a diagnostic test for invasive aspergillosis in immunocompromised critically ill patients with symptoms of respiratory infection: an autopsy-based study. J Clin Microbiol. 2011;49:3783\u20137.","journal-title":"J Clin Microbiol"},{"issue":"1\u20132","key":"11_CR22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1439-0507.1996.tb00078.x","volume":"39","author":"R Kappe","year":"1996","unstructured":"Kappe R, Schulze-Berge A, Sonntag HG. Evaluation of eight antibody tests and one antigen test for the diagnosis of invasive aspergillosis. Mycoses. 1996;39(1\u20132):13\u201323.","journal-title":"Mycoses"},{"issue":"3","key":"11_CR23","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1086\/422009","volume":"190","author":"KA Marr","year":"2004","unstructured":"Marr KA, Balajee SA, McLaughlin L, et al. Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. J Infect Dis. 2004;190(3):641\u20139.","journal-title":"J Infect Dis"},{"key":"11_CR24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1128\/JCM.05267-11","volume":"50","author":"A Onishi","year":"2012","unstructured":"Onishi A, Sugiyama D, Kogata Y, et al. Diagnostic accuracy of serum 1,3-\u03b2-d-glucan for Pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis. J Clin Microbiol. 2012;50:7\u201315.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"11_CR25","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jmii.2014.06.009","volume":"48","author":"S He","year":"2015","unstructured":"He S, Hang J-P, Zhang L, et al. A systematic review and metaanalysis of diagnostic accuracy of serum 1, 3-\u03b2-d-glucan for invasive fungal infection: focus on cutoff levels. J Microbiol Immunol Infect. 2015;48(4):351\u201361.","journal-title":"J Microbiol Immunol Infect"},{"issue":"1","key":"11_CR26","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1128\/JCM.00506-08","volume":"47","author":"RY Hachem","year":"2009","unstructured":"Hachem RY, Kontoyiannis DP, Chemaly RF, et al. Utility of galactomannan enzyme immunoassay and (1,3) beta-d-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients. J Clin Microbiol. 2009;47(1):129\u201333.","journal-title":"J Clin Microbiol"},{"issue":"6","key":"11_CR27","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1086\/527382","volume":"46","author":"L Senn","year":"2008","unstructured":"Senn L, Robinson JO, Schmidt S, et al. 1,3-Beta-d-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia. Clin Infect Dis. 2008;46(6):878\u201385.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"11_CR28","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/02681219780001441","volume":"35","author":"M Yoshida","year":"1997","unstructured":"Yoshida M, Obayashi T, Iwama A, et al. Detection of plasma (1\u00a0\u2192\u00a03)-beta-d-glucan in patients with Fusarium, Trichosporon, Saccharomyces and Acremonium fungaemias. J Med Vet Mycol. 1997;35(5):371\u20134.","journal-title":"J Med Vet Mycol"},{"issue":"2","key":"11_CR29","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1086\/421944","volume":"39","author":"Z Odabasi","year":"2004","unstructured":"Odabasi Z, Mattiuzzi G, Estey E, et al. Beta-d-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis. 2004;39(2):199\u2013205.","journal-title":"Clin Infect Dis"},{"issue":"8941","key":"11_CR30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0140-6736(95)91152-9","volume":"345","author":"T Obayashi","year":"1995","unstructured":"Obayashi T, Yoshida M, Mori T, et al. Plasma (1\u00a0\u2192\u00a03)-beta-d-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet. 1995;345(8941):17\u201320.","journal-title":"Lancet"},{"issue":"1","key":"11_CR31","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1128\/JCM.43.1.299-305.2005","volume":"43","author":"C Pazos","year":"2005","unstructured":"Pazos C, Ponton J, Del Palacio A. Contribution of (1\u00a0\u2192\u00a03)-beta-d-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan. J Clin Microbiol. 2005;43(1):299\u2013305.","journal-title":"J Clin Microbiol"},{"key":"11_CR32","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1128\/JCM.03567-13","volume":"52","author":"A Sulahian","year":"2014","unstructured":"Sulahian A, Porcher R, Bergeron A, et al. Use and limits of (1\u00a0\u2192\u00a03)-\u03b2-d-glucan assay (fungitell), compared to galactomannan determination (platelia Aspergillus), for diagnosis of invasive aspergillosis. J Clin Microbiol. 2014;52:2328\u201333.","journal-title":"J Clin Microbiol"},{"key":"11_CR33","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1128\/JCM.02091-07","volume":"46","author":"F Persat","year":"2008","unstructured":"Persat F, Ranque S, Derouin F, et al. Contribution of the (1\u00a0\u2192\u00a03)-\u03b2-d-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol. 2008;46:1009\u201313.","journal-title":"J Clin Microbiol"},{"key":"11_CR34","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1128\/JCM.00773-12","volume":"50","author":"CR Sims","year":"2012","unstructured":"Sims CR, Jaijakul S, Mohr J, et al. Correlation of clinical outcomes with \u03b2-glucan levels in patients with invasive candidiasis. J Clin Microbiol. 2012;50:2104\u20136.","journal-title":"J Clin Microbiol"},{"key":"11_CR35","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/cid\/cis456","volume":"55","author":"S Jaijakul","year":"2012","unstructured":"Jaijakul S, Vazquez JA, Swanson RN, Ostrosky-Zeichner L. (1,3)-\u03b2-d-glucan as a prognostic marker of treatment response in invasive candidiasis. Clin Infect Dis. 2012;55:521\u20136.","journal-title":"Clin Infect Dis"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-016-0011-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11046-016-0011-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-016-0011-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T10:28:34Z","timestamp":1600511314000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11046-016-0011-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,3]]},"references-count":35,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["11"],"URL":"https:\/\/doi.org\/10.1007\/s11046-016-0011-x","relation":{},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,3]]}}}